Silverarc Capital Management, LLC Iveric Bio, Inc. Transaction History

Silverarc Capital Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$17.24 - $23.95 $1.54 Million - $2.13 Million	-89,121 Reduced 50.25%	88,243 $1.89 Million
Q3 2022 Oct 28, 2022	BUY	$9.4 - $18.59 $1.67 Million - $3.3 Million	177,364 New	177,364 $3.18 Million
Q4 2021 Feb 14, 2022	SELL	$13.83 - $18.78 $414,900 - $563,400	-30,000 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$7.07 - $17.5 $212,100 - $525,000	30,000 New	30,000 $487,000
Q2 2021 Aug 16, 2021	SELL	$5.69 - $7.17 $739,944 - $932,408	-130,043 Closed	0 $0

Q4 2020 Feb 16, 2021	BUY	$5.65 - $7.66 $734,742 - $996,129	130,043 New	130,043 $899,000

250K

40K

Ticker ISEE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,078,000
Description
IVERIC bio, Inc., a biopharmaceutical company, discovers and develops novel treatments for retinal diseases with a focus on age-related and orphan inherited retinal diseases (IRDs). The company develops Zimura, an inhibitor of complement factor C5 comprising GATHER1, which has completed Phase 2/3 clinical trial; and GATHER2 that is in Phase 3 cl...

Get notified when there are updates to the investment portfolio of Silverarc Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Silverarc Capital Management, LLC with notifications on news.